IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Atlas Venture Associates IX, LLC

Q2 2019 Holdings

Filed 2019-08-06 | 7 holdings | $93.5K | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Intellia Therapeutics Inc(NTLA)COM45826J105$26.4K1,615,32128.3%
Synlogic IncCOM87166L100$24.1K2,651,96325.8%
Spero Therapeutics Inc(SPRO)COM84833T103$15.8K1,376,96816.9%
Surface Oncology IncCOM86877M209$13.1K4,645,45314.0%
Unum Therapeutics IncCOM903214104$8.8K3,361,5359.4%
Carbon Black IncCOM14081R103$3.0K181,2733.2%
Snap Inc(SNAP)CL A83304A106$2.1K150,1602.3%